Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 7 December 2004
Vol. 2004, Issue 262, p. tw443
[DOI: 10.1126/stke.2622004tw443]

EDITORS' CHOICE

TRANSCRIPTION Targeting Cancer with Gene Expression Inhibitor

Inhibition of vascular endothelial growth factor (VEGF) signaling is a promising target for anticancer therapies because the growth factor helps cancer cells experiencing hypoxia to promote angiogenesis. Cells respond to hypoxia by activating the hypoxia-inducible factor (HIF), a transcription factor that increases expression of genes (like that for VEGF) that contain hypoxia response elements (HREs). Olenyuk et al. therefore set out to create a small molecule that would inhibit sequence-specific binding of HIF-1 to target genes. They designed a synthetic pyrrole-imidazole polyamide to interact with the HRE in the VEGF promotor. Exposure of cells to the inhibitor at concentrations of 0.2 to 1 micromolar inhibited expression of VEGF mRNA and protein. Microarray analysis of gene expression showed that expression of other HIF-regulated genes was also reduced. With the use of a threshold of a twofold change in expression, the inhibitor altered expression of about 1.5% of the genes monitored. Some genes were commonly affected by the targeted polyamide and a mismatched polyamide control, however. The authors propose that such targeting of hypoxia-induced gene expression might provide a way to inhibit angiogenesis and consequent tumor growth.

B. Z. Olenyuk, G.-J. Zhang, J. M. Klco, N. G. Nickols, W. G. Kaelin Jr., P. B. Dervan, Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc. Natl. Acad. Sci. U.S.A. 101, 16768-16773 (2004). [Abstract] [Full Text]

Citation: Targeting Cancer with Gene Expression Inhibitor. Sci. STKE 2004, tw443 (2004).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882